Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Capital Expenditures (2020 - 2025)

Caribou Biosciences has reported Capital Expenditures over the past 6 years, most recently at $1.4 million for Q4 2025.

  • Quarterly Capital Expenditures rose 137.67% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 80.24% year-over-year, with the annual reading at $1.4 million for FY2025, 80.24% up from the prior year.
  • Capital Expenditures was $1.4 million for Q4 2025 at Caribou Biosciences, up from -$1.5 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $11.1 million in Q4 2023 and troughed at -$3.6 million in Q4 2024.
  • The 5-year median for Capital Expenditures is $498500.0 (2022), against an average of $853500.0.
  • The largest YoY upside for Capital Expenditures was 6762.96% in 2021 against a maximum downside of 4392.86% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at $1.9 million in 2021, then tumbled by 74.85% to $466000.0 in 2022, then soared by 2272.75% to $11.1 million in 2023, then tumbled by 132.63% to -$3.6 million in 2024, then surged by 137.67% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Capital Expenditures are $1.4 million (Q4 2025), -$1.5 million (Q3 2025), and $1.3 million (Q2 2025).